The Externally-led Patient-Focused Drug Development meeting focused on mitochondrial disease was held on March 29, 2019. We were thrilled with the level of participation by the community! We thank all of you who took the time to be involved either in-person or remotely.
We now shift our focus to to the Voice of the Patient report. The report was reviewed and approved by the Food and Drug Administration (FDA). Click on the report below to download your copy. Below the Voice of the Patient report are resource materials outlined in that report.
Thank you in advance for your continued support of the UMDF mission and our quest to facilitate the development of treatments and cures for mitochondrial disease.